Hawkins, Inc. (HWKN) SEC Filings & Earnings Calls
EquiReason read 12 Hawkins, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-08-14 — Reported a director or officer change (departure, election, appointment or pay arrangement).
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 2.8B
- P/E TTM
- 34.3
- Dividend yield
- 0.6%
- 52-week
- —
- Next earnings
- 26 Oct, in 2 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
14 Aug 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
Loss of board member could reduce diversity of oversight, but no disagreement suggests minimal operational risk.
“Resignation effective immediately, no disagreement stated.”
29 Jul 202610-QHawkins reported Q1 FY2027 results: revenue +8% YoY, but gross margin contracted 130 bps and operating income fell 6% YoY due to LIFO and freight cost pressure.earningsopen
Figures in the filing · each found in the filing text
| Sales · Q1-2027 | $316M | +8% y/y |
| Gross profit · Q1-2027 | $74M | +2% y/y |
| Operating income · Q1-2027 | $39M | -6% y/y |
| Net income · Q1-2027 | $28M | -3% y/y |
| Diluted earnings per share · Q1-2027 | $1.35 | -4% y/y |
| Operating cash flow · Q1-2027 | $35M | +12% y/y |
| Capital expenditures · Q1-2027 | $12M | -14% y/y |
| Water Treatment segment sales · Water Treatment · Q1-2027 | $158M | +6% y/y |
| Food & Health Sciences segment sales · Food & Health Sciences · Q1-2027 | $97M | +9% y/y |
| Industrial Solutions segment sales · Industrial Solutions · Q1-2027 | $60M | +10% y/y |
Risks flagged
Gross margin compression from LIFO and freight costs
“During the current quarter, the LIFO reserve increased, and gross profit decreased, by $1.9 million. In the same period a year ago, the LIFO reserve increased, and gross profit decreased, by $0.6 million.” · word for word
SG&A growth outpacing sales growth
“Selling, general and administrative expenses increased $4.3 million, or 14%, to $35.3 million, or 11% of sales, for the three months ended June 28, 2026, from $31.0 million, or 11% of sales, in the same period a year ago.”
Earnout liability exposure
“The WaterSurplus earnout liability is based on a target of accumulated gross profit for the first five years of the acquisition. The earnout liability was discounted and recorded at the present value of the anticipated maximum payout amount, which is a Level 3 input.” · word for word
29 Jul 20268-K · 2.02Revenue $316M (+8% y/y); Gross profit $74M (+2% y/y); Diluted EPS $1.35 (-4% y/y)earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2027 | $316M | +8% y/y |
| Gross profit · Q1-2027 | $74M | +2% y/y |
| Diluted EPS · Q1-2027 | $1.35 | -4% y/y |
| Net income · Q1-2027 | $28M | -3% y/y |
| Adjusted EBITDA · Q1-2027 | $57M | +1% y/y |
| Operating cash flow · Q1-2027 | $35M | +12% y/y |
| Free cash flow · Q1-2027 | $24M | +30% y/y |
Risks flagged
Raw material volatility and LIFO reserve impacting gross margins.
“raw material volatility; LIFO reserve increased, and gross profit decreased, by $1.9 million”
Freight costs not fully recovered, pressuring margins.
“higher freight costs of approximately $1.3 million that were not fully recovered” · word for word
18 Jun 2026DEF 14AProxy statement filed for annual meeting; no material events beyond routine governance and compensation disclosure.open
Figures in the filing · each found in the filing text
| Income Before Income Taxes · FY2026 | $119M | |
| Water Treatment Segment Operational Performance Measure · Water Treatment · FY2026 | $68M | |
| Industrial Solutions Segment Operational Performance Measure · Industrial Solutions · FY2026 | $19M |
Risks flagged
Key Person Risk
“Richard G. Erstad, Former VP, Secretary, and General Counsel ceased service as an executive officer as of December 28, 2025, and retired from the company on May 13, 2026.” · word for word
13 May 202610-KRisks named: Raw material price volatility, Supply chain disruption, Tariff risk, Environmental liabilityopen
Risks flagged
Raw material price volatility
“Fluctuations in the prices and availability of our raw materials, which may be cyclical in nature, could have a material adverse effect on our operations and the margins we receive on sales of our products.” · word for word
Supply chain disruption
“Disruptions within our supply chain have negatively impacted, and could continue to negatively impact, our production, financial condition and results of operations.” · word for word
Tariff risk
“Tariffs imposed by the United States or other countries could substantially impact the price or supply of raw materials.” · word for word
Environmental liability
“Environmental problems at any of our facilities could result in significant unexpected costs.” · word for word
13 May 20268-K · 2.02Sales $266M (+8% y/y); Gross profit $54M (+4% y/y); Diluted EPS $0.74 (-5% y/y)earningsopen
Figures in the filing · each found in the filing text
| Sales · Q4-2026 | $266M | +8% y/y |
| Gross profit · Q4-2026 | $54M | +4% y/y |
| Diluted EPS · Q4-2026 | $0.74 | -5% y/y |
| Operating cash flow · Q4-2026 | $38M | +22% y/y |
| Gross profit · FY2026 | $245M | +9% y/y |
| Operating cash flow · FY2026 | $144M | +30% y/y |
| Diluted EPS · FY2026 | $3.91 | -3% y/y |
| Net income · FY2026 | $82M | |
| Adjusted EBITDA · FY2026 | $179M | +6% y/y |
| Water Treatment segment sales · Water Treatment · FY2026 | $543M | +22% y/y |
Risks flagged
EPS decline due to acquisition-related costs; food end-market softness.
“EPS down 5% in Q4 due to $4.4M acquisition costs; Food and Health Sciences segment flat due to softness in food and nutrition end markets.”
28 Jan 202610-QHawkins reported Q3 fiscal 2026 results with revenue up 7.9% YoY but net income down 4.7% YoY, driven by acquisition-related costs and segment mix.earningsopen
Figures in the filing · each found in the filing text
| Sales · Q3-2026 | $244M | +8% y/y |
| Net income · Q3-2026 | $14M | -5% y/y |
| Gross profit · Q3-2026 | $51M | +5% y/y |
| Operating income · Q3-2026 | $23M | +7% y/y |
| Diluted earnings per share · Q3-2026 | $0.69 | -4% y/y |
| Water Treatment segment sales · Water Treatment · Q3-2026 | $120M | +21% y/y |
| Food & Health Sciences segment sales · Food & Health Sciences · Q3-2026 | $70M | -10% y/y |
| Industrial Solutions segment sales · Industrial Solutions · Q3-2026 | $54M | +10% y/y |
| Capital expenditures · 9M-2026 | $39M | +29% y/y |
| Free cash flow · 9M-2026 | $68M | +35% y/y |
Risks flagged
Acquisition integration risk
“WaterSurplus operating loss of $1.6 million for Q3 and $1.8 million YTD.”
Segment concentration risk
“Food & Health Sciences segment operating income declined 33.4% YoY.”
28 Jan 20268-K · 2.02Revenue $244M (+8% y/y); Net income $14M (-5% y/y); Diluted EPS $0.69 (-4% y/y); Guidance: Expects continued pricing pressure in food end markets; organic growth recovery in FY2027; acquisition accretion in FY2027.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2026 | $244M | +8% y/y |
| Net income · Q3-2026 | $14M | -5% y/y |
| Diluted EPS · Q3-2026 | $0.69 | -4% y/y |
| Adjusted EBITDA · Q3-2026 | $35M | +3% y/y |
| Trailing 12-month Adjusted EBITDA · TTM-2026 | $179M | |
| Operating cash flow · Q3-2026 | $35M | |
| Water Treatment segment revenue · Water Treatment · Q3-2026 | $121M | +21% y/y |
| Food & Health Sciences segment revenue · Food & Health Sciences · Q3-2026 | $70M | -10% y/y |
| Industrial Solutions segment revenue · Industrial Solutions · Q3-2026 | $54M | +10% y/y |
| Gross profit · Q3-2026 | $51M | +5% y/y |
Guidance
Expects continued pricing pressure in food end markets; organic growth recovery in FY2027; acquisition accretion in FY2027.
Management positive on overall trajectory but cautious on Food & Health Sciences; expects organic growth recovery in FY2027; acquisition accretion in FY2027.
Risks flagged
Pricing pressure in food end markets
“Looking to the fourth quarter, we will continue to see pricing pressures within food end markets and are focused on returning our Food and Health Sciences segment to growth.” · word for word
Acquisition-related expense drag on EPS
“impact on operating income and earnings per share from the first-quarter acquisition of WaterSurplus, due to $4 to $5 million per quarter of expense related to the acquisition associated with amortization, earn-out accretion and interest expense” · word for word
Food & Health Sciences segment decline
“Food & Health Sciences segment sales decreased $7.7 million, or 10%... gross profit decreased $2.5 million, or 15%” · word for word
29 Oct 202510-QHawkins reported Q2 FY2026 results with revenue growth of 13.5% YoY, driven by acquisitions, but net income declined 6.3% due to higher interest expense.earningsopen
Figures in the filing · each found in the filing text
| Sales · Q2-2026 | $280M | +14% y/y |
| Net Income · Q2-2026 | $23M | -6% y/y |
| Diluted EPS · Q2-2026 | $1.08 | -7% y/y |
| Gross Profit · Q2-2026 | $68M | +12% y/y |
| Operating Cash Flow · H1-2026 | $71M | +20% y/y |
| Free Cash Flow · H1-2026 | $47M | +23% y/y |
Risks flagged
Integration Risk from Multiple Acquisitions
“We completed multiple acquisitions in fiscal 2025 and the first half of fiscal 2026, including the large WaterSurplus acquisition, which increases integration complexity.”
Increased Leverage Risk
“Long-term debt increased to $268.3 million from $138.9 million at March 30, 2025, primarily to fund the WaterSurplus acquisition.”
Environmental Remediation Liability
“We recorded a liability of $7.7 million related to estimated remediation expenses associated with PCBs discovered at our Rosemount, MN facility.”
29 Oct 20258-K · 2.02Revenue $280M (+14% y/y); Net income $23M (-6% y/y); Diluted EPS $1.08 (-7% y/y); Guidance: Expect Water Treatment and Industrial Solutions to grow; Food & Health Sciences flat to downearningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $280M | +14% y/y |
| Net income · Q2-2026 | $23M | -6% y/y |
| Diluted EPS · Q2-2026 | $1.08 | -7% y/y |
| Adjusted EBITDA · Q2-2026 | $50M | +9% y/y |
| Gross profit · Q2-2026 | $68M | +12% y/y |
| Water Treatment segment revenue · Water Treatment · Q2-2026 | $151M | +21% y/y |
| Food & Health Sciences segment revenue · Food & Health Sciences · Q2-2026 | $73M | +2% y/y |
| Industrial Solutions segment revenue · Industrial Solutions · Q2-2026 | $57M | +11% y/y |
Guidance
Expect Water Treatment and Industrial Solutions to grow; Food & Health Sciences flat to down
Management expects continued growth in Water Treatment and Industrial Solutions; Food & Health Sciences facing headwinds; acquisition expected accretive in FY2027.
Risks flagged
Acquisition-related costs ($17M annualized) dragging EPS; competitive pricing pressure in Food & Health Sciences; tough H2 comps for Food & Health Sciences.
“expected to incur $17 million of annualized expense related to the acquisition; Food & Health Sciences gross profit decreased primarily as a result of lower selling prices as a result of competitive pricing pressures”
Hawkins, Inc. — questions
- What did Hawkins, Inc. file recently?
- 12 SEC filings in the last 12 months. Latest: 8-K on 2026-08-14 — Reported a director or officer change (departure, election, appointment or pay arrangement)
Every figure on this page comes from Hawkins, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.